Live Breaking News & Updates on Technical assessment committee

Stay informed with the latest breaking news from Technical assessment committee on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Technical assessment committee and stay connected to the pulse of your community

FG to 'comprehensively' address Isheri flooding – Minister - Blueprint Newspapers Limited

FG to 'comprehensively' address Isheri flooding – Minister - Blueprint Newspapers Limited
blueprint.ng - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from blueprint.ng Daily Mail and Mail on Sunday newspapers.

Lagos , Nigeria , Isheri , Ogun , Oyan , Nigeria-general- , Ogun-state , Funmi-imuetinyan , Joseph-terlumun-utsev , Ministry-of-water-resources , Ministerial-committee , Ogun-osun-river-basin-development-authority

Lazio Cinema International to launch its second call for 2022

29/11/2022 - The Lazio Region is putting forward 5 million euros for international film co-productions involving Lazio-based audiovisual firms, with the application process opening on 7 December

Italy , Italian , Daniele-leodori , Giovanna-pugliese , Regional-councillor-for-economic-development-paolo-orneli , Lazio-cinema-international , Technical-assessment-committee , Lazio-region , Deputy-vice-president-daniele , Film-delegate-giovanna-pugliese , Regional-councillor , Economic-development-paolo

Lazio Cinema International to launch its second call for 2022

29/11/2022 - The Lazio Region is putting forward 5 million euros for international film co-productions involving Lazio-based audiovisual firms, with the application process opening on 7 December

Italy , Italian , Daniele-leodori , Giovanna-pugliese , Regional-councillor-for-economic-development-paolo-orneli , Lazio-cinema-international , Technical-assessment-committee , Lazio-region , Deputy-vice-president-daniele , Film-delegate-giovanna-pugliese , Regional-councillor , Economic-development-paolo

DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of COVID-19 Drug 2-DG

The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.

Indian-pharma , Technical-assessment-committee , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , First-come-served-basis , Active-pharmaceutical-ingredient , Drug-licensing-authorities , Covid-19-drug-2-dg , Drdo-covid-drug-2-dg

drdo 2dg drug: DRDO invites EoI to transfer technology of 2-DG drug for bulk production

According to the EoI document, applications should be submitted before June 17 through email. "The EoI submitted by industries will be scrutinised by a Technical Assessment Committee (TAC). Only up to 15 industries will be given ToT on their capabilities, technical hand holding capability of DRDO and on First Come First Served Basis," it said.

Technical-assessment-committee , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , First-come-served-basis , Active-pharmaceutical-ingredient , Drug-licensing-authorities , Drdo-2dg-drug , Inmas

DRDO invites Express of Interest for bulk production of COVID drug 2-DG

New Delhi [India], June 9 (ANI): The Defence Research and Development Organisation (DRDO), which developed 2 -Deoxy-D-Glucose (2-DG), a drug used for the treatment of COVID-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industries for production.

New-delhi , Delhi , India , Shalini-bhardwaj , Technical-assessment-committee , Technology-to , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , Indian-pharmaceutical

DRDO To Transfer Technology Of Anti-COVID Drug '2-DG' To India Pharma Firms, Invites EoI

DRDO To Transfer Technology Of Anti-COVID Drug '2-DG' To India Pharma Firms, Invites EoI
by Swarajya Staff - Jun 9, 2021 07:25 AM
DRDO Logo (Pic Via Wikipedia)
The Defence Research and Development Organisation (DRDO) has sought Expression of Interest (EoI) for transfer of technology for bulk manufacturing of the 2-Deoxy-D-Glucose (2-DG), a drug developed by the DRDO for treatment of Covid-19 patients.
The drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of the DRDO, in collaboration with Dr Reddy's Laboratories (DRL), Hyderabad.
2-DG is a glucose analogue, which has the 2-hydroxyl group replaced by hydrogen. The molecule is transported in cells by the glucose transporters on the cell membrane but it cannot undergo further glycolysis and act as inhibitor of glycolysis. Therefore, cells with higher glucose uptake, for example tumor cells, virally infected cells, inflammatory cells have also a higher uptake of 2-DG.

Hyderabad , Andhra-pradesh , India , Technical-assessment-committee , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , Drug-controller-general , Come-first-served

DRDO invites EoI to transfer technology of 2-DG drug for bulk production

The 2-DG was developed by the Institute of Nuclear Medicine and Allied Sciences, a lab of DRDO, in collaboration with Dr. Reddy’s Laboratories.

Technical-assessment-committee , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , Active-pharmaceutical-ingredient , Drug-licensing-authorities , Defence-research-and-development-organisation , Drdo , 2-dg

DRDO invites EoIs for 2-DG technology transfer for bulk production

Last date to submit EoI applications through email is June 17. EoI submitted by industries will be scrutinised by a Technical Assessment Committe, a DRDO statement said

India , Sudhir-chandana , Technical-assessment-committee , Development-organisation , Defence-research , First-come-served-basis , Active-pharmaceutical-ingredient , Drug-licencing-authorities , Good-manufacturing-practices , Drdo-invites-eois , 2-dg-technology-transfer , Bulk-production

DRDO invites EoI to transfer technology of COVID 2-DG drug for bulk production

According to the EoI document, applications should be submitted before June 17 through email

Hyderabad , Andhra-pradesh , India , Technical-assessment-committee , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Nuclear-medicine , Allied-sciences , First-come-served-basis , Active-pharmaceutical-ingredient